Published in Biochim Biophys Acta on July 16, 1982
Proteoglycans from pig aorta. Comparative study of their interactions with lipoproteins. Biochem J (1986) 0.77
A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol (1995) 4.43
A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation (1994) 3.57
Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions. Proc Natl Acad Sci U S A (1988) 2.57
Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem (1996) 2.33
A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology (2008) 2.21
A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb (1994) 2.07
Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: an in vitro and ex vivo study of remodeling bone. J Bone Miner Res (1995) 2.01
A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation (1992) 1.98
Rat model of perinatal hypoxic-ischemic brain damage. J Neurosci Res (1999) 1.86
Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas. Clin Cancer Res (1999) 1.84
Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology (2000) 1.75
Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. J Neurochem (1995) 1.65
Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo. J Bone Miner Res (1997) 1.63
Iron in the brain. Nutr Rev (1993) 1.58
Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J Neurosci Res (2004) 1.57
Receptor-mediated transcytosis of transferrin across the blood-brain barrier. J Neurosci Res (1987) 1.51
Characterization of a novel brain-derived microglial cell line isolated from neonatal rat brain. Glia (2001) 1.51
Regional brain iron, ferritin and transferrin concentrations during iron deficiency and iron repletion in developing rats. J Nutr (1997) 1.45
Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum (1998) 1.44
Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J Neurosci Res (2001) 1.38
A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb (1992) 1.38
Hyaluronan enhances contraction of collagen by smooth muscle cells and adventitial fibroblasts: Role of CD44 and implications for constrictive remodeling. Circ Res (2001) 1.34
A more sensitive assay discriminating galactosamine and glucosamine in mixtures. Anal Biochem (1979) 1.31
Interleukin 1 amplifies receptor-mediated activation of phospholipase A2 in 3T3 fibroblasts. Proc Natl Acad Sci U S A (1988) 1.29
Ferritin: a novel mechanism for delivery of iron to the brain and other organs. Am J Physiol Cell Physiol (2007) 1.29
Insight into the pathophysiology of restless legs syndrome. J Neurosci Res (2000) 1.26
Surgically induced osteoarthritis in the rat results in the development of both osteoarthritis-like joint pain and secondary hyperalgesia. Osteoarthritis Cartilage (2006) 1.26
Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages. Exp Cell Res (1997) 1.22
Oligosaccharide sequences of endothelial cell surface heparan sulfate proteoglycan with affinity for lipoprotein lipase. J Biol Chem (1994) 1.20
Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level. Arthritis Rheum (2000) 1.19
Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors. J Rheumatol (1999) 1.18
Viruses and the versatile macrophage. Br Med Bull (1985) 1.15
Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions. J Biol Chem (1999) 1.14
Mechanisms and regulation of transferrin and iron transport in a model blood-brain barrier system. Neuroscience (2003) 1.14
NPC 15669 inhibits the reversed passive Arthus reaction in rats by blocking neutrophil recruitment. J Pharmacol Exp Ther (1992) 1.12
Acute and chronic effects of developmental iron deficiency on mRNA expression patterns in the brain. J Neural Transm Suppl (2006) 1.12
Cellular distribution of ferritin subunits in postnatal rat brain. J Comp Neurol (1998) 1.11
Variations in dietary iron alter brain iron metabolism in developing rats. J Nutr (2000) 1.11
Aortic pulse wave velocity, elasticity, and composition in a nonhuman primate model of atherosclerosis. Circ Res (1978) 1.10
Do oligodendrocytes mediate iron regulation in the human brain? Ann Neurol (1989) 1.10
Cellular iron status influences the functional relationship between microglia and oligodendrocytes. Glia (2006) 1.09
What providers should know about community cancer control. Cancer Pract (1997) 1.09
Isolation and preliminary characterization of proteoglycans dissociatively extracted from human aorta. J Biol Chem (1981) 1.09
N-(fluorenyl-9-methoxycarbonyl) amino acids, a class of antiinflammatory agents with a different mechanism of action. Proc Natl Acad Sci U S A (1991) 1.08
Existing and emerging mechanisms for transport of iron and manganese to the brain. J Neurosci Res (1999) 1.08
Iron and neurodegenerative disorders. Brain Res Bull (2001) 1.08
Abnormal localization of iron regulatory protein in Alzheimer's disease. Brain Res (1998) 1.08
Iron, transferrin, and ferritin in the rat brain during development and aging. J Neurochem (1994) 1.06
Cellular distribution of iron in the brain of the Belgrade rat. Neuroscience (1999) 1.03
Aortic total glycosaminoglycan and dermatan sulfate changes in atherosclerotic rhesus monkeys. Lab Invest (1978) 1.03
Identification and initial characterization of 5000 expressed sequenced tags (ESTs) each from adult human normal and osteoarthritic cartilage cDNA libraries. Osteoarthritis Cartilage (2001) 1.02
Comparative metabolism of aspartame in experimental animals and humans. J Toxicol Environ Health (1976) 1.02
Identification and localization of divalent metal transporter-1 (DMT-1) in term human placenta. Placenta (2000) 1.01
Acute toxicity of cesium and rubidium compounds. Toxicol Appl Pharmacol (1975) 1.00
Muscular dystrophy syndrome in the Cornish chicken. Am J Vet Res (1970) 0.99
Reduction in pulse wave velocity and improvement of aortic distensibility accompanying regression of atherosclerosis in the rhesus monkey. Circ Res (1980) 0.99
Cellular differences in lipoprotein lipase-mediated uptake of low density lipoproteins. J Biol Chem (1994) 0.99
A study of atherosclerosis regression in Macaca mulatta. I. Design of experiment and lesion induction. Exp Mol Pathol (1979) 0.99
Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain. J Comp Neurol (1993) 0.99
The distribution of transferrin immunoreactivity in the rat central nervous system. Brain Res (1986) 0.98
Distribution of divalent metal transporter-1 in the monkey basal ganglia. Neuroscience (2004) 0.97
Changes in iron histochemistry after hypoxic-ischemic brain injury in the neonatal rat. J Neurosci Res (1999) 0.97
CKbeta-8 [CCL23], a novel CC chemokine, is chemotactic for human osteoclast precursors and is expressed in bone tissues. J Cell Physiol (2000) 0.95
Oligodendrocyte progenitor cells internalize ferritin via clathrin-dependent receptor mediated endocytosis. J Neurosci Res (2000) 0.95
Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorption. J Bone Miner Res (2001) 0.94
Aluminum access to the brain: a role for transferrin and its receptor. Proc Natl Acad Sci U S A (1990) 0.94
Macrophage secretory products selectively stimulate dermatan sulfate proteoglycan production in cultured arterial smooth muscle cells. Am J Pathol (1990) 0.94
2,6-Diamino-N-([1-(1-oxotridecyl)-2-piperidinyl] methyl)hexanamide (NPC 15437): a novel inhibitor of protein kinase C interacting at the regulatory domain. Mol Pharmacol (1992) 0.94
Transferrin is required for normal distribution of 59Fe and 54Mn in mouse brain. J Neurol Sci (1999) 0.93
Wound healing: a paradigm for lumen narrowing after arterial reconstruction. J Vasc Surg (1998) 0.93
Distribution of injected iron 59 and manganese 54 in hypotransferrinemic mice. J Lab Clin Med (1996) 0.93
Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues. Arthritis Rheum (1999) 0.93
Hypoxia-inducible factor pathway activation in restless legs syndrome patients. Eur J Neurol (2011) 0.92
Relationship of temperature and humidity to conception rate of Holstein cows in subtropical climate. J Dairy Sci (1974) 0.92
Interleukin-1beta increases binding of the iron regulatory protein and the synthesis of ferritin by increasing the labile iron pool. Biochim Biophys Acta (2000) 0.91
Proteoglycan structure and function as related to atherosclerosis. Ann N Y Acad Sci (1985) 0.91
2-Iminopiperidine and other 2-iminoazaheterocycles as potent inhibitors of human nitric oxide synthase isoforms. J Med Chem (1996) 0.90
Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque. J Biol Chem (2000) 0.90
Comparative primate atherosclerosis. I. Tissue cholesterol concentration and pathologic anatomy. Exp Mol Pathol (1975) 0.90
Metabolism and turnover of cell surface-associated heparan sulfate proteoglycan and chondroitin sulfate proteoglycan in normal and cholesterol-enriched macrophages. Arterioscler Thromb (1991) 0.89
cDNA cloning by amplification of circularized first strand cDNAs reveals non-IRE-regulated iron-responsive mRNAs. Biochem Biophys Res Commun (2000) 0.89
The effect of inhibitors of inducible nitric oxide synthase on chronic colitis in the rhesus monkey. J Pharmacol Exp Ther (1997) 0.89
The soluble form of E-selectin is an asymmetric monomer. Expression, purification, and characterization of the recombinant protein. J Biol Chem (1994) 0.88
Identification of iron responsive genes by screening cDNA libraries from suppression subtractive hybridization with antisense probes from three iron conditions. Nucleic Acids Res (2000) 0.88
Biochemical characteristics of dissociatively isolated aortic proteoglycans and their binding capacity to hyaluronic acid. J Biol Chem (1983) 0.88
Distribution of transferrin and ferritin binding in normal and multiple sclerotic human brains. J Neurol Sci (1999) 0.88
Interleukin 1 stimulates prostaglandin synthesis and cyclic AMP accumulation in Swiss 3T3 fibroblasts: interactions between two second messenger systems. J Cell Physiol (1989) 0.88
A study of atherosclerosis regression in Macaca mulatta. II. Chemical changes in arteries from animals with atherosclerosis induced for 19 months then regressed for 24 months at plasma cholesterol concentrations of 300 or 200 mg/dl. Exp Mol Pathol (1980) 0.88
Artery wall derived proteoglycan-plasma lipoprotein interaction: lipoprotein binding properties of extracted proteoglycans. Atherosclerosis (1987) 0.88
Angiochemical and tissue cholesterol changes of Macaca fascicularis fed an atherogenic diet for 3 years. Exp Mol Pathol (1978) 0.88
Inhibition of IFN-gamma-induced Ia antigen expression on synovial fibroblasts by IL-1. J Immunol (1989) 0.88
The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans. J Biol Chem (1998) 0.87
Differential effects of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, on IL-1 treated bovine and human cartilage/chondrocyte cultures. Osteoarthritis Cartilage (2000) 0.87
Iron deficiency alters H- and L-ferritin expression in rat brain. Cell Mol Biol (Noisy-le-grand) (2000) 0.87
Slowly miscible cholesterol pools in progressing and regressing atherosclerotic aortas. Proc Soc Exp Biol Med (1973) 0.87
Reduction in the structural changes of experimental osteoarthritis by a nitric oxide inhibitor. Osteoarthritis Cartilage (1999) 0.87
Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains. Cell Mol Biol (Noisy-le-grand) (2000) 0.86
Distinct synthetic and structural characteristics of proteoglycans produced by cultured artery smooth muscle cells of atherosclerosis-susceptible pigeons. J Biol Chem (1988) 0.86